We have a report that sodomites are infecting pieces of pins or needles and wedging them into the change slot in public telephones. It is well known that this is virtually 100% effective in passing AIDS if done within about 3 days of a person being pricked by the needle, and assuming the days are fairly mild. What are the ramifications? Certain AIDS victims, mostly sodomites and whores, have long called for the intentional infecting of straights in such manner, as well as other methods of offensive action. Thus, we can call this attempted murder. The courts absolutely will NOT call this murder.
So, the non-infected citizen, world wide, must respond to this as attempted murder and do what he feels is appropriate in a society which fails to defend him. This will mean action of various kinds depending on the individual. At least, we must be very careful. We must also understand that world governments are outlawing self-defense weapons and responses, while they are protecting sodomite murderers. It seems to me that the God fearing will have to deal with this form of murder on their own and apply the standard they feel is called for.
Jesus, just before being crucified and leaving his disciples, said, "get a sword." This was not to launch a Christian Jihad-- It was for self-defense, and Jesus clearly did not trust the Roman government to protect his disciples in all cases of lawlessness. You figure it out.
By MF-- VANCOUVER- Stung by accusations that drug companies are making billions at the expense of AIDS victims, Glaxo-Wellcome Plc. <GLXO.L> said on Monday it was starting to pay the community back.
It invited AIDS activists, researchers and community workers attending the 11th International Conference on AIDS to a special lunch to hear about its "positive action program" to work with AIDS groups, governments and health care providers.
"We, the private sector, the pharmaceutical industry, have to recognize our responsibility," Jim Niedel, executive director for research and development at Glaxo, said.
"We are eager to play our role," he added. But he said governments and community groups had to do their parts too.
Glaxo and other companies have been strongly criticized by groups that say their drugs are too expensive, are not widely enough available and are financially out of the reach of victims in developing countries.
Demonstrators descended on Abbott Laboratories' <ABT.N> display booth at the conference on Monday, strewing its promotional pamphlets and accusing it of profiteering. Glaxo has been the victim of similar protests in the past.
Dr. Julio Montaner, a Canadian AIDS expert and co-chairman of the conference, defended the profit motive.
"So far, most research and development carried out by the pharmaceutical industry has been responsible for the vast number of medications available today," he said.
Calling the positive action program "quite impressive," he urged other drug companies to follow Glaxo's example. Under the program, Glaxo funds AIDS groups, pays for educational videos, pamphlets and other materials, holds workshops, and helps set up hotlines.
Robin Gorna of the Terrence Higgins Trust, a British AIDS charity, said cooperation could benefit both sides. "They need community advice," she told the meeting. "We need the pharmaceutical industry to give us money."
But those attending the meeting made their concerns clear.
"Is Glaxo-Wellcome prepared to tell us about plans to create expanded drug access in the developing world?" one delegate asked, to applause.
"It cannot be done just by us alone. We will need to create momentum," Anita Kidgell, the company's spokeswoman on anti-viral therapies, told the meeting.
Esther Muia, project director of the Population Council, an international group working on health issues, defended Glaxo.
She described groups working in Tanzania, Zambia, Zimbabwe, Uganda and Kenya, using Glaxo funding to train counselors to warn HIV victims about likely symptoms.
The program had also paid for orphanages for children left parentless by AIDS and gave loans to AIDS victims to help them start businesses.
Several attending the meeting said they thought such programs had value.
"We want to hear what they are doing apart from drugs,"
Joyce Olenja of the University of Nairobi said.
Others were not convinced. "I personally have a problem with drug prices and access to drugs," Jeff Arender of the HIV Consumer Committee in San Diego said. "They need to be morally responsible. I understand business but there are morals involved here too."
Editor: Balaam's Ass Speaks, Steve Van Nattan: I notice that the non-queer folks from Africa are greatful for the help they get from the pharmaceutical companies. It is the sodomite demon possessed gang that gets violent and threatening. They live like dogs (pardon me, you real dogs), and then they expect the rest of the world to give them a free ride and pay for their death style. God has allowed a way for them to die and be removed from our world. They hate God for that, but they cannot poke Him in the eye, so they demand that God fearing folks grovel at their feet. We decline.
BACK TO THE TITLE PAGE